Lovastatin and cholestasis

Yoshida, Eric M.; Levin, Adeera
February 1993
CMAJ: Canadian Medical Association Journal;2/1/1993, Vol. 148 Issue 3, p374
Academic Journal
No abstract available.


Related Articles

  • Sepsis and cholestasis. Paton, Alex // British Medical Journal (Clinical Research Edition);10/6/1984, Vol. 289 Issue 6449, p857 

    Examines the association of cholestasis with sepsis. Cause of cholestasis; Symptoms on the development of sepsis in patients with cholestasis; Sites common in sepsis infection.

  • Discontinue med of dubious benefit? P.F.C. // Cortlandt Forum;05/25/97, Vol. 10 Issue 5, p121 

    Offers advice on discontinuing lovastatin who is not benefiting an 83-year-old woman. Duration of the lovastatin treatment; Cholesterol level.

  • DRUG-INDUCED VANISHING BILE DUCT SYNDROME: RESPONSE TO URSODIOL. O'Brien, Christopher B.; Shields, David S.; Saul, H.; Reddy, K. Rajender // American Journal of Gastroenterology;Jul1996, Vol. 91 Issue 7, p1456 

    Presents a study on drug-induced cholestasis. Treatment for drug-induced cholestasis; Complications of drug-induced cholestasis; Association of vanishing bile duct syndrome with drug-induced cholestasis.

  • cholestasia.  // Taber's Cyclopedic Medical Dictionary;2005, p406 

    A definition of the term "cholestasia" is presented, which means cholestasis.

  • Cholesterol-lowering drug may help women, too. Hurley, Mary Lou // RN;Sep93, Vol. 56 Issue 9, p92 

    Reports on the effectivity of Lovastatin (Mevacor) in treating women with moderately elevated levels of total and low-density lipoprotein (LDL) cholesterol. Effect of estrogen replacement therapy on the efficacy and safety of lovastatin; Study of women on placebo and lovastatin.

  • Nicotinic acid/lovastatin better value than simvastatin for lipid lowering.  // PharmacoEconomics & Outcomes News;6/19/2005, Issue 455, p8 

    Focuses on a study which evaluated the cost performance of nicotinic acid, lovastatin and simvastatin in lowering levels of cholesterol. Direct costs of using simvastatin and nicotinic acid and lovastatin; Cost effectiveness ratio for simvastatin versus nicotinic acid and lovastatin.

  • Therapeutic potential of lovastatin in multiple sclerosis. Sena, Armando; Pedrosa, Rui; Morais, M. Gra├ža // Journal of Neurology;Jun2003, Vol. 250 Issue 6, p754 

    Presents a letter to the editor about the therapeutic effect of lovastatin in patient with multiple sclerosis.

  • Biliary Secretory Failure in Man. Sherlock, Sheila // Annals of Internal Medicine;Sep66, Vol. 65 Issue 3, p397 

    Discusses the billiary secretory failure in man. Anatomy of the biliary system; Definition of cholestasis; Classification of intrahepatic cholestasis.

  • Rhabdomyolysis due to combined treatment with lovastatin and cholestyramine. Chrysanthopoulos, C.; Kounis, Nicholas // BMJ: British Medical Journal (International Edition);5/9/92, Vol. 304 Issue 6836, p1225 

    Comments on cases on rhabdomyolysis after treatment with lovastatin and cholestyramine. Possibility of the interference of lovastatin with muscle metabolism; Effects of vigorous exercise on patients; Predisposition of myopathy by exercise.

  • Rhabdomyolysis and Acute Renal Failure Induced by Combination Lovastatin and Gemfibrozil Therapy. Marais, Gary F.; Larson, Kerry K. // Annals of Internal Medicine;2/1/90, Vol. 112 Issue 3, p228 

    Focuses on rhabdomyolsis and acute renal failure induced by combination lovastatin and gemfibrozil therapy. Function of the lovastatin drug; Definition of myopathy; Suggestion given in the use of gemfibrozil therapy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics